The Community Advisory Board of the Pitt Men’s Study has started planning this year’s World’s AIDS Day Memorial to be held on Tuesday, December 1, 2021.
This year’s service—like last year—will be virtual, and the board’s organizers are asking community organizations and individuals to participate. Last year’s service, which can be viewed on at the link above, included musical performances and tributes to honor people who’ve been affected by HIV and AIDS.
If you’re interested in performing or providing a tribute, please contact Bart Rauluk, Co-Chair of the Pitt Men’s Study Community Advisory Board, at email@example.com. If you know someone who died from HIV/AIDS and would like their name to be read aloud during the annual Circle of Love tribute, you can send an email to Ray Yeo at firstname.lastname@example.org. Please add “Circle of Love” in the subject line.
More information about the World AIDS Day Memorial for 2021 will be posted as it becomes available. If you want to know more about the Pitt Men’s Study and our history, you can go to our history page.
The Centers for Disease Control and Prevention recommended that people who are moderately to severely immunocompromised get an additional dose of the Moderna or Pfizer COVID-19 vaccine after the initial two doses. Widespread vaccination is a critical tool to help stop the pandemic.
Recipients of organ or stem cell transplants
People with advanced or untreated HIV infection
Active recipients of treatment for cancer
People who are taking some medications that weaken the immune system
We spoke with Harold J. Phillips, Director of The White House Office of National AIDS Policy, about what people with HIV need know. “There are three key messages we need to share,” he said:
Everyone over 12 years of age, regardless of HIV status, get vaccinated
Those with advanced HIV disease and/or not on medications, get a third dose of the vaccine
Those in HIV care and treatment who are virally suppressed, talk with your health care provider about the need for an additional dose.
“By working together and spreading the word,” he continued, “we can help keep everyone in our HIV community safe and healthy.”
The aim of this study is to understand how sleep can affect the health of people living with HIV through effects on the immune system. We hope information from this research will help us find ways to improve sleep or lead to treatments that could reduce the bad effects of poor sleep.
The study involves two (2) visits to Montefiore Hospital. Each visit is about one (1) hour.
On the first visit, subjects would complete questionnaires and get a watch-like device similar to a Fitbit. Subjects would wear the device for two (2) weeks to track their sleep patterns. Subjects would also answer a few questions in a diary each morning about their sleep. At the end of two (2) weeks, subjects would return the watch, complete more questionnaires and provide a urine and blood sample.
Subjects will receive up to $100 for their participation. Parking vouchers or bus fare will also be provided.
Please remember that subjects may choose whether they would like to participate in the study. It is completely voluntary and there are no consequences if subjects decide not to.
To learn more about the study, please call the study team at 412-330-1453 or email them at email@example.com. You can also download the study flyer pdf for more information.
Please join us at Shepherd Wellness Community for a Community Open House on Thursday, October 7, 6-8 pm as we honor Scott Peterman, who retired last December (in the midst of the pandemic) after serving 21 years as our Executive Director!
Stop by our center at 4800 Sciota St, Pittsburgh 15224 (one block from West Penn Hospital – use our S. Mathilda St entrance with the awning) to greet Scott, enjoy appetizers and beverages, and see how we have honored him for his two plus decades of faithful service. No RSVP needed, but vaccination and masks required.
For those who cannot attend, we invite you to send greetings to Scott through SWC (firstname.lastname@example.org or by regular mail to our Sciota St. address), with a deadline of August 20 for submissions. All letters will be compiled and presented to Scott.
As we are finally able to honor Scott upon his retirement, we hope you can join us and give him your personal greetings on October 7!
Shepherd Wellness Community is hosting a 2 part Mental Health First Aid In-Person Training on Fridays, June 11 and 18, 9 am – 1 pm. Registration closes June 9 and is limited to 20 vaccinated participants. Any questions or concerns can be directed to Richard Krug at email@example.com.
A message from Rob Ghormoz, Secretary of Intergovernmental Affairs, Office of the Governor…
The Pennsylvania Department of Health today will announce two additional categories of eligible individuals to receive the COVID-19 vaccination as part of Phase 1A. Beginning today, all individuals 65 and older, and individuals ages 16-64 with certain medical conditions, as defined by the Centers for Disease Control and Prevention (CDC) that increase the risk of severe illness from the virus, are eligible for the COVID-19 vaccination. The Departments’ Updated Interim Vaccine Plan can be found here.
Those conditions are outlined by the CDC here and include: Cancer; Chronic kidney disease; COPD (chronic obstructive pulmonary disease); Down Syndrome; Heart conditions such as heart failure, coronary artery disease, or cardiomyopathies; Immunocompromised state (weakened immune system) from solid organ transplant, blood or bone marrow transplant, immune deficiencies, HIV, use of corticosteroids, or use of other immune weakening medicines; Obesity; Severe Obesity; Pregnancy; Sickle cell disease; Smoking; and Type 2 diabetes mellitus.
If you are part of a group that is eligible for vaccination, you can use the Pennsylvania Vaccine Provider Map to find a place to schedule your vaccine. Contact the vaccine provider of your choice directly to schedule an appointment. This map will be updated as more locations receive vaccine. Although a provider may have received vaccine, there is no guarantee that they have open appointments as supply is still very limited. Check back frequently as the map will be updated multiple times per week.
The purpose of the first research study is to investigate brain activity, cognitive functioning, and aging in those living with HIV versus those living without HIV. The human brain and cognitive abilities change as people age, and this research study aims to identify those changes.
The purpose of the second research study is to investigate how chronic cannabis use affects brain activity and cognitive functioning differently in people who are living with HIV and those who are not living with HIV. To study the brain, researchers will be using a series of brain imaging tests, both of which are completely non-invasive. There is no cost to you, and you will receive compensation for your time and travel expenses.
You may be eligible if:
You are between the ages of 19 and 72
You have not had a stroke or been diagnosed with any neurological or psychiatric disorder(s)
You are able to complete a series of mental tasks You are not pregnant or planning to become pregnant
You either regularly use cannabis or do not use cannabis
This research study is sponsored by the National Institute of Mental Health. For more information, please call 412-246-5590 or send an email to firstname.lastname@example.org. You can also download the study brochure.
Getting a flu vaccine during 2020-2021 is more important than ever because of the ongoing COVID-19 pandemic. When you get vaccinated, you reduce your risk of getting sick with flu and possibly being hospitalized or dying from flu. This season, getting a flu vaccine has the added benefit of reducing the overall burden on the health care system and saving medical resources for care of COVID-19 patients.
People with HIV—especially those who have a very low CD4 cell count or who are not taking antiretroviral therapy—are at high risk for serious flu-related complications. For this reason, it is especially important that people with HIV get a flu shot annually. (The nasal spray flu vaccine is not recommended for people with HIV.)
In addition to getting a flu shot every year, people with HIV should take the same everyday preventive actions CDC recommends of everyone, including avoiding people who are sick, covering coughs, and washing hands often.
People with HIV who switch from a stable antiretroviral (ARV) regimen to Delstrigo (doravirine/tenofovir disoproxil fumarate/lamivudine) had a high rate of full suppression of the virus at the three-year mark in a large Phase III clinical trial.
Princy Kumar, MD, of Georgetown University, presented findings from the open-label, randomized, active-controlled, noninferiority DRIVE-SHIFT trial at the virtual HIV Drug Therapy Glasgow meeting.
Delstrigo contains the relatively new non-nucleoside reverse transcriptase inhibitor (NNRTI) Pifeltro (doravirine), which, like Delstrigo, was approved in September 2019.